Page 5 - 《中国药房》2024年7期

CHINA PHARMACY

Volume 35，Number 7， April 15，2024

Semimonthly

Table of Contents

Interpretation of the Guideline for Multi-dimensional and Multi-criteria Comprehensive Evaluation of Chinese
Patent Medicine：weighting of evaluation indicators ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ ZHANG Haili，LIU Bin，WANG Weili，CAO Wenjie，YANG Yijiu，HU Ziteng，
CHEN Yaxin，LIANG Ning，LI Huizhen，CHE Qianzi，ZONG Xingyu，CHEN Zhao，WANG Yanping，SHI Nannan （773）
Obstacles and approaches for the implementation of external long-term prescription dispensing for chronic diseases
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ XU Yuan，JIN Chunlin，SONG Jie，HE Amei，CHEN Minxing （778）

Interpretation and reflection on the Measures for the Administration of Standards for Medicinal Products ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ ZHAO Mengxia，SUN Lina，XU Dan，CHAI Wen，JIANG Xuekong，MAO Zhihai，HE Shengliang （783）
Study on the synergistic effect and mechanism of curcumin combined with zerumbone on the biological behavior
of non-small cell lung cancer cells ⋅⋅⋅⋅⋅⋅⋅⋅ LIU Jiaxin，ZHANG Yun，HUANG Huixian，LI Jianfen，YAO Zhixin （787）

Study on extraction technology of Sophora flavescens-Phellodendron chinense drug pair ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
GUAN Yongmei，TAO Ying，ZOU Chengyu，ZANG Zhenzhong，CHEN Lihua，LIU Lili，CHEN Limei，ZHU Weifeng （793）
Establishment of HPLC fingerprint and content determination of multiple index components in Xiao’er resuqing
oral liquid ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ CUI Junfeng，CUI Shuai，LIANG Xiukun，LI Dongxu，WANG Xinrui，GAO Peng （801）
Improvement mechanism of proanthocyanidins on gentamicin-induced acute kidney injury of rats through SIRT1/

AMPK signaling pathway ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ FU Meili，JIANG Qiang，FU Shengliang，FU Shushan，XIE Taomei，LI Shanshan （807）

Protective effect and mechanism of Longshengzhi capsules on cerebral ischemia-reperfusion injury in rats ⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ FANG Huanle，LI Xiaoming，ZHOU Yaming，ZHANG Xin，LIU Xiaoxi，CHEN Yanbin （813）
Improvement effects of 3，5，6，7，8，3′，4′-heptamethoxyflavone of Fructus Aurantii on rats with damp blockage
of the middle energizer ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ GONG Wenhui，XIE Yating，XIN Li，
YAN Shihao，ZHAO Beibei，ZHENG Yuqing，GUO Jingying，SHANG Jie，ZHENG Peng，ZHANG Jinlian （819）

Multicenter study on the efficacy and safety of 3 kinds of Cephalosporin for injection from centralized procurement
or non-centralized procurement ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LIU Lu，
SONG Cangsang，LI Xingde，DENG Yuqin，MAO Panpan，ZHANG Hanshu，DONG Yanzhen，CHENG Yaoyao （825）
Efficacy， safety and cost-effectiveness evaluation of voriconazole original and generic drugs ⋅⋅⋅ TANG Ganling，
XIE Xiangwei，LUO Xiandan，LU Yanli，JIANG Huixian，LI Jingyi，HUANG Xiaoman，ZHANG Hongliang （831）

Literature analysis of ADR after the listing of apatinib ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ JIN Bingjin，WU Xuehua，WANG Xin，ZHANG Yiwei，SONG Changqing，WANG Yafeng （837）
Meta-analysis of the efficacy and safety of novel oral anticoagulants in the treatment of venous thromboembolism
in cancer patients ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ WANG Zuxiu，LI Xuhuan，YOU Peimeng，ZHU Tingde，CHEN Lixu，YAN Yiqun，PAN Yongping （842）

Rapid health technology assessment of zanubrutinib in the treatment of B cell lymphomas ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ FENG Zhen，LAI Ran （848）
Efficiency and safety of belimumab in the treatment of lupus nephritis in Chinese adults：a meta-analysis ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LI Bojiang，PAN Hongxia，FU Yixing，FANG Meirong，HU Xiang，DONG Jianhua，XIAO Youwen （853）